bioAffinity Technologies (BIAF) Depreciation and Depletion (2022 - 2026)
bioAffinity Technologies has reported Depreciation and Depletion over the past 5 years, most recently at $24408.0 for Q1 2026.
- Quarterly Depreciation and Depletion fell 44.23% to $24408.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $151004.0 through Mar 2026, down 9.73% year-over-year, with the annual reading at $170359.0 for FY2025, 4.94% up from the prior year.
- Depreciation and Depletion was $24408.0 for Q1 2026 at bioAffinity Technologies, down from $37529.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $166284.0 in Q4 2023 and troughed at $800.0 in Q3 2022.
- The 5-year median for Depreciation and Depletion is $38811.0 (2024), against an average of $36543.8.
- Year-over-year, Depreciation and Depletion soared 5536.88% in 2023 and then crashed 74.26% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $7282.0 in 2022, then soared by 2183.49% to $166284.0 in 2023, then crashed by 74.26% to $42806.0 in 2024, then decreased by 12.33% to $37529.0 in 2025, then tumbled by 34.96% to $24408.0 in 2026.
- Per Business Quant, the three most recent readings for BIAF's Depreciation and Depletion are $24408.0 (Q1 2026), $37529.0 (Q4 2025), and $44599.0 (Q3 2025).